Hydrodynamic and species transfer simulations in the USP 4 dissolution apparatus: Considerations for dissolution in a low velocity pulsing flow

Pharmaceutical Research

Volumn 27, Issue 2, 2010, Pages 246-258

  D'Arcy, Deirdre M ^a   Liu, Bo ^a   Bradley, Geoff ^a   Healy, Anne Marie ^a   Corrigan, Owen I ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Computational fluid dynamics (CFD); Dissolution; Flow visualisation; Flow through dissolution apparatus (USP apparatus 4); Hydrodynamics

Indexed keywords

ARTICLE; COMPUTATIONAL FLUID DYNAMICS; COMPUTER SIMULATION; DISSOLUTION; FLOW RATE; HYDRODYNAMICS; LUNG DIFFUSION CAPACITY; PRIORITY JOURNAL;

CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; MICROFLUIDIC ANALYTICAL TECHNIQUES; PULSATILE FLOW; RHEOLOGY; SOLUBILITY; SOLUTIONS;

EID: 77949273316     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-0010-4     Document Type: Article

References (37)

1. W Butler S Bateman 1998 A flow-through dissolution method for a two component drug formulation where the actives have markedly differing solubility properties Int J Pharm 173 211 9 10.1016/S0378-5173(98)00238-5 1:CAS:528:DyaK1cXmt1elsbk%3D (Pubitemid 29027775)
2. J Phillips Y Chen I Wakeling 1989 A flow-through dissolution approach to in vivo/in vitro correlation of adinazolam release from sustained release formulations Drug Dev Ind Pharm 15 2177 95 10.3109/03639048909052526 1:CAS:528:DyaK3cXosVSisQ%3D%3D
3. Y Wu ES Ghaly 2006 Effect of hydrodynamic environment on tablet dissolution using flow-through dissolution apparatus Puerto Rico Health Sciences Journal 25 75 83 16883682
4. VH Sunesen BL Pedersen HG Kristensen A Müllertz 2005 In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media Eur J Pharm Sci 24 305 13 10.1016/j.ejps.2004.11.007 1:CAS:528:DC%2BD2MXhslWmsLc%3D 15734297 (Pubitemid 40283513)
5. LE Stevens PJ Missel 2006 Impact of density gradients on flow-through dissolution in a cylindrical flow cell Pharm Dev Technol 11 529 34 10.1080/10837450600970441 1:CAS:528:DC%2BD28Xht1OnsL3J 17101524 (Pubitemid 44852435)
6. GH Zhang WA Vadino TT Yang WP Cho IA Chaudry 1994 Evaluation of the flow-through cell dissolution apparatus: effects of flow rate, glass beads and tablet position on drug release from different type of tablets Drug Dev Ind Pharm 20 2063 78 10.3109/03639049409050222 1:CAS:528:DyaK2cXkvFWmt7c%3D
7. C Graffner M Särkelä K Gjellan G Nork 1996 Use of statistical experimental design in the further development of a discriminating in vitro release test for ethyl cellulose ER-coated spheres of remoxipride Eur J Pharm Sci 4 73 83 10.1016/0928-0987(95)00033-X 1:CAS:528:DyaK28XhvVKltro%3D (Pubitemid 26096222)
8. SR Cammarn A Sakr 2000 Predicting dissolution via hydrodynamics: salicylic acid tablets in flow through cell dissolution Int J Pharm 201 199 209 10.1016/S0378-5173(00)00415-4 1:CAS:528:DC%2BD3cXktlSlur0%3D 10878326 (Pubitemid 30394665)
9. SS Bhattachar JA Wesley A Fioritto PJ Martin SR Babu 2002 Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus Int J Pharm 236 135 43 10.1016/S0378-5173(02)00027-3 1:CAS:528:DC%2BD38Xhslyms7k%3D 11891077 (Pubitemid 34219380)
10. M Hurtado y de la Peña Y Vargas Alvarado AM Domínguez- Ramírez AR Cortés Arroyo 2003 Comparison of dissolution profiles for albendazole tablets using USP apparatus 2 and 4 Drug Dev Ind Pharm 29 777 84 10.1081/DDC-120021777 12906335 (Pubitemid 36899884)
11. United States Pharmacopeia 32, United States Pharmacopeial Convention, Rockwell, MD, USA; 2009.
12. Guidance for industry: Dissolution testing of immediate release solid oral dosage forms, Centre for Drug Evaluation and Reseach, Food and Drug Administration,U.S. Department of Health and Human Services; 1997.
13. Guidance for Industry: Bioavailability and bioequivalence studies for orally administered drug products-General considerations, Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services; 2003.
14. McCarthy LG, Kosiol C, Healy AM, Bradley G, Sexton JC, Corrigan OI. Simulating the hydrodynamic conditions in the United States Pharmacopeia paddle dissolution apparatus. AAPS PharmSciTech 2003; Vol. 4 Article 22.
15. McCarthy LG, Bradley G, Sexton JC, Corrigan OI, Healy AM. Computational fluid dynamics modeling of the paddle dissolution apparatus: agitation rate, mixing patterns and fluid velocities. AAPS PharmSciTech 2004; Vol. 5 Article 31.
16. J Kukura PE Arratia ES Szalai FJ Muzzio 2003 Engineering tools for understanding the hydrodynamics of dissolution tests Drug Dev Ind Pharm 29 231 9 10.1081/DDC-120016731 1:CAS:528:DC%2BD3sXhvF2is7w%3D 12648020
17. J Kukura JL Baxter FJ Muzzio 2004 Shear distribution and variability in the USP apparatus 2 under turbulent conditions Int J Pharm 279 9 17 10.1016/j.ijpharm.2004.03.033 1:CAS:528:DC%2BD2cXltlyguro%3D 15234789 (Pubitemid 38968637)
18. DM D'Arcy OI Corrigan AM Healy 2006 Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics-dissolution rate implications Eur J Pharm Sci 27 259 67 10.1016/j.ejps.2005.10.007 16314078 (Pubitemid 41831261)
19. Bai G, Armenante P. Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing. J Pharm Sci 2009;98:1511-31
20. DM D'Arcy OI Corrigan AM Healy 2005 Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability J Pharm Pharmacol 57 1243 50 10.1211/jpp.57.10.0002 16259752 (Pubitemid 41545889)
21. Levich VG. Physicochemical hydrodynamics. Englewood Cliffs, N.J., U.S.A.: Prentice Hall Inc.; 1962.
22. A Dokoumetzidis V Papadopoulou G Valsami P Macheras 2008 Development of a reaction-limited model of dissolution: application to official dissolution tests experiments Int J Pharm 355 114 25 10.1016/j.ijpharm.2007.11.056 1:CAS:528:DC%2BD1cXkt1yhtbk%3D 18206324
23. M Kakhi 2009 Classification of the flow regimes in the flow-through cell Eur J Pharm Sci 37 531 44 10.1016/j.ejps.2009.04.003 1:CAS:528: DC%2BD1MXnsFKrtb8%3D 19379811
24. M Kakhi 2009 Mathematical modelling of the fluid dynamics in the flow-through cell Int J Pharm 376 22 40 10.1016/j.ijpharm.2009.04.012 1:CAS:528:DC%2BD1MXntFynt7o%3D 19375490
25. LE Stevens PJ Missel AL Weiner 2008 Controlled flow-through dissolution methodology: a high-performance system Pharm Dev Technol 13 135 53 10.1080/10837450701831179 1:CAS:528:DC%2BD1cXktVCisr0%3D 18379905
26. C Schiller C-P Frölich W Giessmann W Siedmund H Mönnikes N Hosten W Weitschies 2005 Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging Aliment Pharmacol Ther 22 971 9 10.1111/j.1365-2036.2005.02683.x 1:STN:280:DC%2BD2MrovF2jug%3D%3D 16268972 (Pubitemid 41634879)
27. D'Arcy DM, Liu B, O'Dwyer R, Bradley G, Corrigan OI. Dissolution in the flow-through apparatus-use of computational fluid dynamics (CFD) to investigate hydrodynamic effects. AAPS Journal 2008;10 (S2).
28. Mauger J, Ballard J, Brockson R, De S, Gray V, Robinson D. Intrinsic dissolution performance testing of the USP dissolution apparatus 2 (rotating paddle) using modified salicylic acid calibrator tablets: proof of principle. Dissolution Technologies 2003; August:6-15.
29. AH Goldberg WI Higuchi 1968 Improved method for diffusion coefficient determinations employing the silver membrane filter J Pharm Sci 57 1583 5 10.1002/jps.2600570924 1:CAS:528:DyaF1cXkvF2ltrk%3D 5674399
30. M Patrick 1977 Mass transfer by free convection Can J Chem Eng 55 432 8 10.1002/cjce.5450550412 1:CAS:528:DyaE2sXlsVehtL0%3D
31. E Jantratid N Janssen C Reppas J Dressman 2008 Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update Pharm Res 25 1663 76 10.1007/s11095-008-9569-4 1:CAS:528:DC%2BD1cXmslWnu70%3D 18404251
32. DM D'Arcy AM Healy OI Corrigan 2009 Towards determining appropriate hydrodynamic conditions for in vitro in vivo correlations using computational fluid dynamics Eur J Pharm Sci 37 291 9 10.1016/j.ejps.2009.02.016 19491018
33. L Bradshaw A Irimia A Sims M Gallucci R Palmers W Richards 2006 Biomagnetic characterization of spactiotemporal parameters of the gastric slow wave Neurogastroenterol Motil 18 619 31 10.1111/j.1365-2982.2006.00794.x 1:STN:280:DC%2BD28vps1aksQ%3D%3D 16918726 (Pubitemid 44079765)
34. A Pal K Indireshkumar W Schwizer B Abrahamsson M Fried JG Brasseur 2004 Gastric flow and mixing studied using computer simulation Proc R Soc Lond, B, Biol Sci 271 2587 94 10.1098/rspb.2004.2886
35. G Garbacz R-S Wedemeyer S Nagel T Giessmann H Mönnikes CG Wilson W Siegmund W Weitschies 2008 Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses Eur J Pharm Biopharm 70 421 8 10.1016/j.ejpb.2008.05.029 1:CAS:528:DC%2BD1cXhtFOmtbvI 18582568
36. C-Y Perng AS Kearney NR Palepu BR Smith LM Azzarano 2003 Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens Int J Pharm 250 147 56 10.1016/S0378-5173(02)00521-5 1:CAS:528:DC%2BD38Xpt12qs7k%3D 12480281 (Pubitemid 35447945)
37. SA Motz UF Schaefer S Balbach T Eichinger C-M Lehr 2007 Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell Eur J Pharm Biopharm 66 286 95 10.1016/j.ejpb.2006.10.015 1:CAS:528:DC%2BD2sXkslCht7Y%3D 17156983 (Pubitemid 46654772)